BROADCASTS.com

Every week, The American Journal of Managed Care\xae recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care stories included\xa0additional moves by the Trump administration to unravel the Affordable Care Act; Pfizer canceled a round of drug price increases after speaking to the president; advocates for 340B sound the alarm on efforts to reform the program.\n\nRead more about the stories in this podcast:\nPause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision\nCMS Cuts Budget for ACA Marketing to $10 Million for 2019 Plan Year: https://www.ajmc.com/newsroom/cms-cuts-budget-for-aca-marketing-to-10-million-for-2019-plan-year\nWhat We're Reading: Pfizer Halts Price Increases; Azar's Attention Is Split; VA Pick Clears First Hurdle: https://www.ajmc.com/newsroom/what-were-reading-pfizer-halts-price-increases-azars-attention-is-split-va-pick-clears-first-hurdle\n340B Health Says Changing Hospital Eligibility Will Slash Program: https://www.ajmc.com/newsroom/340b-health-says-changing-hospital-eligibility-will-slash-program\nHighmark Reaches Value-Based Contract for Empagliflozin, Fixed-Dose Combinations: https://www.ajmc.com/newsroom/highmark-reaches-valuebased-contract-for-empagliflozin-fixeddose-combinations